Company celebrates new design that delivers improved flexibility,
clarity and control
LONDON--(BUSINESS WIRE)--Feb. 1, 2018--
LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a
market-leading medical technology company, today announced it has
achieved CE Mark for its new PureFlexTM line of adult
arterial cannulae. Engineered to improve the critical link between the
patient and extracorporeal circulation, PureFlex cannulae provide curved
and straight tip options. The phthalate (DEHP)-free flexible tubing
features exceptional transparency and a wire-reinforcement spring to
deliver flexibility without kinking.
“Our decades-long commitment to excellence in cannulation continues with
the addition of the new PureFlex cannulae to our robust portfolio. We
call it ‘the cannulae that can,’” said Alistair Simpson, LivaNova’s
General Manager of its Cardiac Surgery business franchise. “Now with CE
Mark, we are eager to offer this high-quality line of cannulae to
cardiac surgery teams and skilled surgeons, benefitting the full range
of adult conventional cardiac surgery patients and delivering the best
The PureFlex family of adult arterial cannulae meets diverse clinical
needs and is another example of LivaNova’s efforts to transform medical
innovation into meaningful solutions. In addition to PureFlex, LivaNova
offers a comprehensive
portfolio of conventional cannulae with a wide range of tips and
LivaNova PLC is a global medical technology company built on nearly five
decades of experience and a relentless commitment to improve the lives
of patients around the world. LivaNova’s advanced technologies and
breakthrough treatments provide meaningful solutions for the benefit of
patients, healthcare professionals and healthcare systems. Headquartered
in London and with a presence in more than 100 countries worldwide, the
company employs more than 4,500 employees. LivaNova operates as three
business franchises: Cardiac Surgery, Neuromodulation and Cardiac Rhythm
Management, with operating headquarters in Mirandola (Italy),
Houston (U.S.A.) and Clamart (France), respectively.
For more information, please visit www.livanova.com.
Safe Harbor Statement
This news release may include certain statements concerning expectations
for the future that are forward-looking statements as defined by U.S.
federal law. Such forward-looking statements are subject to a variety of
known and unknown risks, uncertainties and other factors that are
difficult to predict and many of which are beyond management's control.
An extensive list of factors that can affect future results are
discussed in LivaNova's Annual Report on Form 10-K and other documents
filed from time to time with the Securities and Exchange Commission.
LivaNova undertakes no obligation to update or revise any
forward-looking statement to reflect new information or events. Actual
results may differ materially from anticipated results.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180201005808/en/
Source: LivaNova PLC
LivaNova PLC Investor Relations and Media
Karen King, +1
Vice President, Investor Relations & Corporate
Deanna Wilke, +1 (281) 727-2764
External Communications Manager